Astrid Hirschmann

1.1k total citations
20 papers, 869 citations indexed

About

Astrid Hirschmann is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Pathology and Forensic Medicine. According to data from OpenAlex, Astrid Hirschmann has authored 20 papers receiving a total of 869 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 7 papers in Pulmonary and Respiratory Medicine and 6 papers in Pathology and Forensic Medicine. Recurrent topics in Astrid Hirschmann's work include Genetic factors in colorectal cancer (5 papers), Ovarian cancer diagnosis and treatment (4 papers) and Cancer Genomics and Diagnostics (3 papers). Astrid Hirschmann is often cited by papers focused on Genetic factors in colorectal cancer (5 papers), Ovarian cancer diagnosis and treatment (4 papers) and Cancer Genomics and Diagnostics (3 papers). Astrid Hirschmann collaborates with scholars based in Germany, Switzerland and United States. Astrid Hirschmann's co-authors include Joachim Diebold, U. Löhrs, Doris Mayr, Klaus Strobel, Oliver Gautschi, Andrea Sendelhofert, Stefan Aebi, Matthias Rössle, Christian Haas and Christian Zietz and has published in prestigious journals such as American Journal Of Pathology, European Journal of Cancer and Journal of Clinical Pathology.

In The Last Decade

Astrid Hirschmann

20 papers receiving 857 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Astrid Hirschmann Germany 13 424 363 311 201 195 20 869
Huiying Piao United States 10 442 1.0× 198 0.5× 715 2.3× 168 0.8× 160 0.8× 10 1.2k
Shuangping Guo China 16 188 0.4× 189 0.5× 382 1.2× 169 0.8× 63 0.3× 50 855
Françoise Drusch France 14 544 1.3× 195 0.5× 215 0.7× 305 1.5× 92 0.5× 17 924
Arnaud Da Cruz Paula United States 21 348 0.8× 210 0.6× 290 0.9× 360 1.8× 332 1.7× 74 1.2k
C. Fisher United Kingdom 12 687 1.6× 221 0.6× 351 1.1× 279 1.4× 23 0.1× 16 1.1k
Steve Gyorffy Canada 14 258 0.6× 220 0.6× 242 0.8× 96 0.5× 102 0.5× 18 798
Michael Churchman United Kingdom 21 409 1.0× 98 0.3× 473 1.5× 223 1.1× 371 1.9× 45 1.1k
Margaret E. Gatti‐Mays United States 16 746 1.8× 170 0.5× 306 1.0× 137 0.7× 41 0.2× 74 1.1k
Awatif Al‐Nafussi United Kingdom 10 116 0.3× 113 0.3× 153 0.5× 69 0.3× 172 0.9× 23 505

Countries citing papers authored by Astrid Hirschmann

Since Specialization
Citations

This map shows the geographic impact of Astrid Hirschmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Astrid Hirschmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Astrid Hirschmann more than expected).

Fields of papers citing papers by Astrid Hirschmann

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Astrid Hirschmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Astrid Hirschmann. The network helps show where Astrid Hirschmann may publish in the future.

Co-authorship network of co-authors of Astrid Hirschmann

This figure shows the co-authorship network connecting the top 25 collaborators of Astrid Hirschmann. A scholar is included among the top collaborators of Astrid Hirschmann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Astrid Hirschmann. Astrid Hirschmann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hirschmann, Astrid, et al.. (2023). Protein atlas of fibroblast specific protein 1 (FSP1)/S100A4.. PubMed. 38(12). 1391–1401. 6 indexed citations
2.
Klier, John, Sebastian Fuchs, Sven Reese, et al.. (2015). Nanoparticulate CpG Immunotherapy in RAO-Affected Horses: Phase I and IIa Study. Journal of Veterinary Internal Medicine. 29(1). 286–293. 28 indexed citations
3.
Gautschi, Oliver, Thilo Zander, Klaus Strobel, et al.. (2013). A Patient with Lung Adenocarcinoma and RET Fusion Treated with Vandetanib. Journal of Thoracic Oncology. 8(5). e43–e44. 72 indexed citations
4.
Gautschi, Oliver, Solange Peters, Vincent Zoete, et al.. (2013). Lung adenocarcinoma with BRAF G469L mutation refractory to vemurafenib. Lung Cancer. 82(2). 365–367. 26 indexed citations
5.
Hirschmann, Astrid, et al.. (2012). Simultaneous Analysis of HER2 Gene and Protein on a Single Slide Facilitates HER2 Testing of Breast and Gastric Carcinomas. American Journal of Clinical Pathology. 138(6). 837–844. 23 indexed citations
6.
Gautschi, Oliver, Chantal Pauli, Klaus Strobel, et al.. (2012). A Patient With BRAF V600E Lung Adenocarcinoma Responding to Vemurafenib. Journal of Thoracic Oncology. 7(10). e23–e24. 104 indexed citations
7.
Dijkstra, Jeroen R., D.A.M. Heideman, Gerrit A. Meijer, et al.. (2012). KRAS mutation analysis on low percentage of colon cancer cells: the importance of quality assurance. Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin. 462(1). 39–46. 22 indexed citations
8.
Rössle, Matthias, Astrid Hirschmann, & Joachim Diebold. (2011). Mutational spectrum and therapy response of metastasized GIST in Central Switzerland – A population-based study. European Journal of Cancer. 47(9). 1305–1311. 6 indexed citations
9.
Zimmermann, Anne‐Katrin, Astrid Hirschmann, Dagmar Pfeiffer, Bruno E. Paredes, & Joachim Diebold. (2010). FISH analysis for diagnostic evaluation of challenging melanocytic lesions.. PubMed. 25(9). 1139–47. 11 indexed citations
10.
Varella‐Garcia, Marileila, Joachim Diebold, David A. Eberhard, et al.. (2009). EGFR fluorescence in situ hybridisation assay: guidelines for application to non-small-cell lung cancer. Journal of Clinical Pathology. 62(11). 970–977. 96 indexed citations
11.
12.
Ihrler, Stephan, Christoph Weiler, Astrid Hirschmann, et al.. (2007). Intraductal carcinoma is the precursor of carcinoma ex pleomorphic adenoma and is often associated with dysfunctional p53. Histopathology. 51(3). 362–371. 45 indexed citations
13.
Mayr, Doris, Astrid Hirschmann, U. Löhrs, & Joachim Diebold. (2006). KRAS and BRAF mutations in ovarian tumors: A comprehensive study of invasive carcinomas, borderline tumors and extraovarian implants. Gynecologic Oncology. 103(3). 883–887. 173 indexed citations
14.
Haas, Christian J., Joachim Diebold, Astrid Hirschmann, H. Rohrbach, & U. Löhrs. (1999). In serous ovarian neoplasms the frequency of Ki-ras mutations correlates with their malignant potential. Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin. 434(2). 117–120. 29 indexed citations
15.
16.
Haas, Christian J., et al.. (1999). Microsatellite Analysis in Serous Tumors of the Ovary. International Journal of Gynecological Pathology. 18(2). 158–162. 33 indexed citations
17.
18.
Zietz, Christian, Matthias Rössle, Christian Haas, et al.. (1998). MDM-2 Oncoprotein Overexpression, p53 Gene Mutation, and VEGF Up-Regulation in Angiosarcomas. American Journal Of Pathology. 153(5). 1425–1433. 147 indexed citations
19.
Haas, Christian J., Astrid Hirschmann, Andrea Sendelhofert, et al.. (1998). Improvement of Nonradioactive DNA in Situ Hybridization. Biotechnic & Histochemistry. 73(4). 228–232. 5 indexed citations
20.
Hirschmann, Astrid, et al.. (1993). The intelligent help system COMFOHELP. User Modeling and User-Adapted Interaction. 3(3). 249–282. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Huiying Piao Breakdown of academic impact, for papers by Shuangping Guo Breakdown of academic impact, for papers by Françoise Drusch Breakdown of academic impact, for papers by Arnaud Da Cruz Paula Breakdown of academic impact, for papers by C. Fisher Breakdown of academic impact, for papers by Steve Gyorffy Breakdown of academic impact, for papers by Michael Churchman Breakdown of academic impact, for papers by Margaret E. Gatti‐Mays Breakdown of academic impact, for papers by Awatif Al‐Nafussi
Rankless by CCL
2026